JONATHAN D ROOT
CIK 1225480 · last filed 2026-07-17
JONATHAN D ROOT is a corporate insider who has filed 74 SEC Form 4 insider transactions across 9 companies since 2007. The most recent filing, for EWTX, was dated Jul 17, 2026. Across all open-market trades the lifetime net is +$9.5M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $2.04B across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$2.04B
9
74
$9.53M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| EWTX | Director | 15,625 | $43.52 | $680.0K | $250.0K | 7 | 2026-07-17 |
| OMDA | Director | 191,877 | $23.67 | $4.54M | $0 | 8 | 2026-07-07 |
| CARL | Director | 716,221 | $13.82 | $9.90M | $7.00M | 2 | 2026-06-22 |
| Inari Medical, Inc. (NARI) Delisted | Director | 0 | $79.97 | $0 | $4.81M | 14 | 2025-02-19 |
| eFFECTOR Therapeutics, Inc. (EFTRW) Delisted | 10%+ Owner | 129,365 | $0.00 | $78 | -$4.37M | 14 | 2022-08-03 |
| ARS Pharmaceuticals, Inc. (SBTX) Delisted | Director | 95,588 | $5.87 | $561.1K | $2.04M | 6 | 2022-06-13 |
| GWRE | 10%+ Owner | 11,878,173 | $170.53 | $2.03B | $0 | 1 | 2012-01-30 |
| MXL | 10%+ Owner | 3,378 | $74.98 | $253.3K | -$201.4K | 2 | 2011-05-26 |
| Altus Pharmaceuticals Inc. (ALTU) Delisted | Director | — | $10.12 | — | $0 | 3 | 2008-06-13 |
Recent Filings
74 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-07-17 | EWTX | Grant (A) | — | $0 | EDGAR |
| 2026-07-07 | OMDA | Grant (A) | +820 | $0 | EDGAR |
| 2026-06-22 | CARL | Grant (A) | +13,698 | $0 | EDGAR |
| 2026-06-18 | OMDA | Grant (A) | +10,882 | $0 | EDGAR |
| 2026-04-07 | OMDA | Grant (A) | +882 | $0 | EDGAR |
| 2026-01-07 | OMDA | Grant (A) | +915 | $0 | EDGAR |
| 2025-12-04 | OMDA | Other (J) | −4,550,278 | $0 | EDGAR |
| 2025-10-07 | OMDA | Grant (A) | +657 | $0 | EDGAR |
| 2025-07-24 | CARL | Mixed | +6,126,072 | $7.00M | EDGAR |
| 2025-07-08 | OMDA | Grant (A) | +237 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.